Royal Bank of Canada
LVGO

Royal Bank of Canada’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Royal Bank of Canada’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-232,252
Closed -$32.5M – 7508
2020
Q3 		$32.5M Buy
232,252
+85,149
+58% +$10.4M 0.01% 800
2020
Q2 		$11.1M Buy
147,103
+132,945
+939% +$6.96M ﹤0.01% 1399
2020
Q1 		$404K Sell
14,158
-31,277
-69% -$810K ﹤0.01% 3801
2019
Q4 		$1.14M Buy
45,435
+11,935
+36% +$285K ﹤0.01% 3346
2019
Q3 		$584K Buy
+33,500
New +$1.01M ﹤0.01% 3739

Royal Bank of Canada's LVGO Position: Q4 2020 in Review

Royal Bank of Canada sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 232,252 shares — an estimated $32.5M sold.

Royal Bank of Canada first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $32.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Royal Bank of Canada reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 232,252 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $32.5M.
  • Royal Bank of Canada first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Royal Bank of Canada's Livongo Health, Inc. Common Stock position peaked at $32.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.